Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine development against malaria.

Kai Matuschewski1

  • 1Department of Parasitology, Heidelberg University School of Medicine, Germany. kai_matuschewski@med.uni-heidelberg.de

Current Opinion in Immunology
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposing the hidden: establishing immunity to Plasmodium liver stage infection.

Trends in parasitology·2025
Same author

Plasmodium falciparum gametogenesis essential protein 1 (GEP1) is a transmission-blocking target.

FEBS letters·2025
Same author

Stage-dependent expression and vacuolar localization of Plasmodium berghei chloroquine resistance transporter (CRT).

Molecular and biochemical parasitology·2025
Same author

Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil.

EMBO molecular medicine·2025
Same author

Negative Perception of Bats, Exacerbated by the SARS-CoV-2 Pandemic, May Hinder Bat Conservation in Northern Uganda.

Sustainability·2025
Same author

Red pulp macrophages clear parasites, while marginal metallophilic and marginal zone macrophages support CD4<sup>+</sup> T cell activation during <i>Plasmodium yoelii</i> infection.

Frontiers in immunology·2025
Same journal

The food additive microbial transglutaminase is a potential new environmental inducer of autoimmune diseases.

Current opinion in immunology·2026
Same journal

Mapping the synovial immune ecosystem in rheumatoid arthritis: cellular cartography and pathotype-guided immune restoration.

Current opinion in immunology·2026
Same journal

Noncanonical ion channel signaling in neurovascular barrier regulation and immune cell trafficking.

Current opinion in immunology·2026
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
See all related articles

Developing a malaria vaccine is crucial for protecting children and pregnant women in Africa. New research focuses on a specific parasite ligand to create a tailored vaccine for young women, complementing existing efforts like the RTS,S vaccine.

Area of Science:

  • Malariology
  • Vaccinology
  • Infectious Disease Research

Background:

  • Malaria significantly impacts child and maternal health in sub-Saharan Africa.
  • Existing malaria vaccines like RTS,S are undergoing clinical evaluation.
  • Pregnancy-associated malaria requires targeted vaccine strategies.

Purpose of the Study:

  • To evaluate the RTS,S malaria vaccine in young children.
  • To develop a tailored subunit vaccine for young women using identified parasite ligands.
  • To explore complementary approaches for safe and effective malaria vaccine development.

Main Methods:

  • Phase IIb clinical trial of the RTS,S vaccine in children.
  • Identification of parasite-encoded ligands involved in pregnancy-associated malaria.

Related Experiment Videos

  • Generation of transgenic yellow fever viruses and attenuated vaccine lines via reverse genetics.

    • Main Results:

    • The RTS,S vaccine was evaluated in a Phase IIb trial.
    • A key parasite ligand implicated in pregnancy malaria was identified.
    • Reverse genetics approaches were explored for vaccine enhancement.

    Conclusions:

    • Targeted subunit vaccines can be rationally developed for specific high-risk groups.
    • Complementary approaches like transgenic viruses and attenuated lines may improve vaccine efficacy.
    • Continued research is essential for developing effective malaria vaccines for vulnerable populations.